Inogen (INGN) Net Margin Growth (1y) (2014 - 2026)
Inogen (INGN) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 67.00 |
| 10 | Inogen | 151.59 Mn | 46.05 Mn | 43.27 Mn | 128.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 128.00 |
| Mar 31, 2026 | -207.00 |
| Dec 31, 2025 | 1,449.00 |
| Sep 30, 2025 | 28.00 |
| Jun 30, 2025 | 114.00 |
| Mar 31, 2025 | 1,102.00 |
| Dec 31, 2024 | -9,976.00 |
| Sep 30, 2024 | 4,772.00 |
| Jun 30, 2024 | 545.00 |
| Mar 31, 2024 | 952.00 |
| Dec 31, 2023 | 15,885.00 |
| Sep 30, 2023 | -4,541.00 |
| Jun 30, 2023 | -901.00 |
| Mar 31, 2023 | -1,108.00 |
| Dec 31, 2022 | -4,279.00 |
| Sep 30, 2022 | -2,419.00 |
| Jun 30, 2022 | -764.00 |
| Mar 31, 2022 | -1,600.00 |
| Dec 31, 2021 | -1,366.00 |
| Sep 30, 2021 | 1,771.00 |